# Biofrontera (BFRI) — Earnings

BFRI · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/bfri/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2026 |
| Period end | Jun 30, 2026 |
| EPS actual | −$0.05 |
| EPS estimate | −$0.11 |
| EPS surprise | +52.38% |
| Revenue surprise | +26.35% |
| Revenue | $12.0M |
| Revenue estimate | $9.5M |
| Reported | Aug 13, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1858685/000149315226037834/form10-q.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/ba076e24-efcc-586f-942e-afa651f2967d.html) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2026 | Aug 13, 2026 | −$0.11 | −$0.05 | 52.38% | $9.5M | $12.0M |
| Q1 2026 | May 14, 2026 | −$0.12 | −$0.41 | -256.52% | $10.3M | $10.1M |
| Q4 2025 | Mar 19, 2026 | $0.20 | $0.20 | 0.00% | $16.1M | $17.1M |
| Q3 2025 | Nov 12, 2025 | −$0.58 | −$0.62 | -6.90% | $7.0M | $7.0M |
| Q2 2025 | Aug 13, 2025 | −$0.42 | −$0.57 | -35.71% | $8.3M | $9.0M |
| Q1 2025 | May 15, 2025 | −$0.22 | −$0.47 | -118.60% | $10.6M | $8.6M |
| Q4 2024 | Mar 20, 2025 | −$0.03 | −$0.19 | -660.00% | $14.6M | $12.6M |
| Q3 2024 | Nov 13, 2024 | −$0.84 | −$0.98 | -17.37% | $10.0M | $9.0M |
| Q2 2024 | Aug 14, 2024 | −$0.77 | −$0.05 | 93.51% | $8.2M | $7.8M |
| Q1 2024 | May 15, 2024 | −$1.17 | −$2.88 | -146.15% | $10.9M | $7.9M |
| Q4 2023 | Mar 15, 2024 | −$1.19 | $4.45 | 473.95% | $11.5M | $10.6M |
| Q3 2023 | Nov 9, 2023 | −$3.79 | −$4.64 | -22.59% | $8.4M | $8.9M |
| Q2 2023 | Aug 11, 2023 | −$43.37 | −$7.23 | 83.33% | $6.2M | $5.8M |
| Q1 2023 | May 12, 2023 | −$3.90 | −$5.60 | -43.59% | $9.2M | $8.7M |
| Q4 2022 | Mar 8, 2023 | −$2.20 | −$2.10 | 4.55% | $10.3M | $10.1M |
| Q3 2022 | Nov 14, 2022 | −$5.80 | −$2.20 | 62.07% | $4.3M | $4.3M |
| Q2 2022 | Aug 12, 2022 | −$6.80 | −$1.00 | 85.29% | $4.5M | $4.5M |
| Q1 2022 | May 13, 2022 | −$3.00 | $6.40 | 313.33% | $9.8M | $9.8M |
| Q4 2021 | Apr 8, 2022 | −$3.60 | −$25.80 | -616.67% | $9.2M | $9.2M |
| Q3 2021 | Nov 30, 2021 | $0.00 | −$40.00 | 0.00% | — | $4.3M |

## Frequently Asked Questions

### When did Biofrontera (BFRI) last report earnings?

Biofrontera last reported on Aug 13, 2026, covering fiscal Q2 2026.

### Did BFRI beat earnings estimates?

Yes. Biofrontera reported EPS of −$0.05 for Q2 2026 against a −$0.11 estimate — a 52.38% beat.

### How much revenue did BFRI report last quarter?

Biofrontera reported $12.0M in revenue for Q2 2026, against a consensus estimate of $9.5M.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).